Effect of Lycopene on Pharmacokinetic and Pharmacodynamics of Gliclazide in Diabetic Animal Models-Juniepr Publishers
Diabetes mellitus is one of the
metabolic disorders associated with high blood sugar levels. Utilization
of natural drugs among patients under diabetes mellitus pharmacotherapy
is across the board. To examine the
pk-pd(pharmacodynamic-pharmacokinetic) interactions of lycopene and
gliclazide in animal models and to understand the safety &
effectiveness. Single and multiple dose
interaction studies were carried out in normal rats, diabetes induced
rats and rabbits to evaluate the effect of lycopene on the gliclazide
activity. Blood samples from the study animals were used for the
estimation insulin and glucose levels by using radioimmunoassay method
and chemistry analyzer (automated) respectively. Homeostasis model
assessment used for determination of β-cell function. Additionally,
sophisticated HP-LC technique used for analysis of diabetic rabbits
serum samples for gliclazide.Gliclazide produces significant
reduction in blood glucose levels in diabetic animals. However, tests
examined from gliclazide in blend with lycopene indicated more prominent
diminishment in blood glucose concentration in animals with diabetes.The study concludes that the
lycopene along with gliclazide shows the significant pharmacodynamics
interaction but doesn’t establish pharmacokinetics interaction up on
single and multiple-dose treatment in animals.
To read more... Fulltext in Journal of Complementary Medicine & Alternative Healthcare in Juniper Publishers
Comments
Post a Comment